Clinical Trial Record

Return to Clinical Trials

Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma


2002-08-01


2025-10-30


2025-10-30


1122

Study Overview

Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma

RATIONALE: Collecting and storing samples of blood and tissue from family members of patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This clinical trial is collecting blood and tissue samples from family members of patients with pancreatic disease, pancreatic cancer, and melanoma.

OBJECTIVES: * To collect clinical history, family history, and blood and/or tissue samples from family members of patients diagnosed with pancreatic diseases, pancreatic cancer, or melanoma. * To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic cancer, or other cancers. OUTLINE: Study participants undergo collection of blood and/or tissue samples as well as survey data for inclusion in a familial data and tissue registry. Participants complete two baseline surveys regarding their personal, family, health, and environmental exposure histories and regarding their opinions on cancer and cancer screening. Patients also complete a follow-up survey at 1 year and undergo review of their medical records.

  • Familial Pancreatic Cancer
  • OTHER: biologic sample preservation procedure
  • OTHER: medical chart review
  • OTHER: survey administration
  • 355-06
  • R01CA097075-08 (U.S. NIH Grant/Contract)
  • CDR0000613097 (REGISTRY Identifier) (REGISTRY: NCI)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2009-01-31  

N/A  

2024-10-17  

2009-01-31  

N/A  

2024-10-21  

2009-02-03  

N/A  

2024-10  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
Primary Outcome MeasuresMeasure DescriptionTime Frame
Collection of familial data and biospecimens in a data and tissue repository for familial pancreas researchbaseline
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:
1

    DISEASE CHARACTERISTICS:

  • Meets 1 of the following criteria:


  • Has at least 2 blood relatives with pancreatic cancer (both must be related)
  • Has at least 1 blood relative with pancreatic cancer and 1 with melanoma (both must be related)

  • PATIENT CHARACTERISTICS:

  • Mentally competent and able to provide informed consent
  • Able to understand and read English

  • PRIOR CONCURRENT THERAPY:

  • Not specified

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • National Cancer Institute (NCI)

  • PRINCIPAL_INVESTIGATOR: Shounak Majumder, M.D., Mayo Clinic

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available